A detailed history of State Street Corp transactions in Bioventus Inc. stock. As of the latest transaction made, State Street Corp holds 676,501 shares of BVS stock, worth $7.23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
676,501
Previous 487,285 38.83%
Holding current value
$7.23 Million
Previous $2.8 Million 188.61%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.73 - $11.95 $1.08 Million - $2.26 Million
189,216 Added 38.83%
676,501 $8.08 Million
Q2 2024

Aug 14, 2024

BUY
$3.96 - $6.93 $1.49 Million - $2.61 Million
376,091 Added 338.23%
487,285 $2.8 Million
Q2 2023

Aug 14, 2023

SELL
$0.93 - $3.64 $400,145 - $1.57 Million
-430,264 Reduced 79.46%
111,194 $321,000
Q1 2023

May 15, 2023

SELL
$1.07 - $2.95 $28,463 - $78,472
-26,601 Reduced 4.68%
541,458 $579,000
Q4 2022

Feb 14, 2023

BUY
$1.81 - $8.14 $126,846 - $570,459
70,081 Added 14.07%
568,059 $1.48 Million
Q3 2022

Nov 15, 2022

SELL
$6.54 - $9.08 $75,151 - $104,338
-11,491 Reduced 2.26%
497,978 $3.49 Million
Q2 2022

Aug 15, 2022

BUY
$6.82 - $13.82 $550,271 - $1.12 Million
80,685 Added 18.82%
509,469 $3.48 Million
Q1 2022

May 16, 2022

BUY
$11.65 - $15.28 $410,639 - $538,589
35,248 Added 8.96%
428,784 $6.05 Million
Q4 2021

Feb 14, 2022

BUY
$12.37 - $16.77 $3.03 Million - $4.1 Million
244,638 Added 164.3%
393,536 $5.7 Million
Q3 2021

Nov 15, 2021

BUY
$13.7 - $17.25 $224,666 - $282,882
16,399 Added 12.38%
148,898 $2.11 Million
Q2 2021

Aug 16, 2021

BUY
$13.75 - $18.8 $955,020 - $1.31 Million
69,456 Added 110.17%
132,499 $2.33 Million
Q1 2021

May 17, 2021

BUY
$11.49 - $19.21 $724,364 - $1.21 Million
63,043 New
63,043 $963,000

Others Institutions Holding BVS

About Bioventus Inc.


  • Ticker BVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 61,664,200
  • Market Cap $659M
  • Description
  • Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...
More about BVS
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.